• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Saturday, June 14, 2025
  • Login
News Mirror
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Mirror
No Result
View All Result
Home Lifestyle Health & Fitness

AustralaSian COVID-19 Trial opens in India

News Mirror by News Mirror
March 1, 2021
in Health & Fitness, National
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

RelatedPosts

Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions

Pravek Kalp Unveils Ashwagandha Capsules to Combat Summer Fatigue

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Related Posts

Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions
Health & Fitness

Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions

May 14, 2025
Pravek Kalp Unveils Ashwagandha Capsules to Combat Summer Fatigue
Health & Fitness

Pravek Kalp Unveils Ashwagandha Capsules to Combat Summer Fatigue

April 21, 2025
Terna Speciality Hospital & Research Centre, Navi Mumbai, Re-launches Advanced Cathlab, Bringing World-Class Cardiac Care
Health & Fitness

Terna Speciality Hospital & Research Centre, Navi Mumbai, Re-launches Advanced Cathlab, Bringing World-Class Cardiac Care

April 19, 2025
A Complete Guide to IVF Treatment Costs in Gurgaon
Health & Fitness

A Complete Guide to IVF Treatment Costs in Gurgaon

April 10, 2025
Krushi Prasar Foundation’s Medical Camp Highlights the Hidden Health Crisis in Farming
Health & Fitness

Krushi Prasar Foundation’s Medical Camp Highlights the Hidden Health Crisis in Farming

April 4, 2025
Sushain Revolutionizes Healthcare with Expert Online Medical Doctor Consultation
Health & Fitness

Sushain Revolutionizes Healthcare with Expert Online Medical Doctor Consultation

April 4, 2025
Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

MLA Ludhiana South Rajinderpal Kaur Chhina, bestowed with the title of Iron Lady

MLA Ludhiana South Rajinderpal Kaur Chhina, bestowed with the title of Iron Lady

March 21, 2023
World Leaders Summit 2023 held in House of Lords at London followed by the Bharat Samman Award

World Leaders Summit 2023 held in House of Lords at London followed by the Bharat Samman Award

September 22, 2023

Trending.

Kingston Powers Tomorrow: Enabling the Future of AI with High-Performance Solutions at COMPUTEX 2025

Kingston Powers Tomorrow: Enabling the Future of AI with High-Performance Solutions at COMPUTEX 2025

May 22, 2025
Walplast’s CSR Initiative Enhances Education for Girls Across India

Walplast’s CSR Initiative Enhances Education for Girls Across India

June 10, 2025
Say Hello to the Smartest Way to Sound — Ooka Audio Launches TWINS 707 Bluetooth Ceiling Speakers

Say Hello to the Smartest Way to Sound — Ooka Audio Launches TWINS 707 Bluetooth Ceiling Speakers

May 28, 2025
LANXESS significantly increases earnings in fiscal year 2024

LANXESS significantly increases earnings in fiscal year 2024

May 12, 2025
Lotus Derma Botanics Enters the Skincare Arena

Lotus Derma Botanics Enters the Skincare Arena

May 28, 2025
News Mirror

© 2022 News Mirror

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Follow Us

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Mirror

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In